These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genetic polymorphisms and atherosclerosis. Galton DJ Monogr Atheroscler; 1986; 14():113-8. PubMed ID: 3090427 [No Abstract] [Full Text] [Related]
5. [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus]. Kronenberg F; Auinger M; Dieplinger H Acta Med Austriaca; 1999; 26(5):142-7. PubMed ID: 11512190 [TBL] [Abstract][Full Text] [Related]
6. [Apolipoproteins in atherosclerosis]. Carino C; Rauseo R; Tiboni GM; De Martiis M Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762 [No Abstract] [Full Text] [Related]
7. Mapping of lipoprotein particles with monoclonal antibodies in diabetes and atherosclerosis. Fievet C; Parra H; Luyeye I; Demarquilly C; Fievet P; Fruchart JC; Bertrand M; Lablanche JM; Drouin P; Gross P Monogr Atheroscler; 1985; 13():134-41. PubMed ID: 3937049 [No Abstract] [Full Text] [Related]
8. Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis? Marcovina SM; Koschinsky ML Circulation; 1999 Sep; 100(11):1151-3. PubMed ID: 10484533 [No Abstract] [Full Text] [Related]
9. [Lipoprotein(a)--atherogenic waste product of evolution?]. Kronenberg F; Utermann G Wien Med Wochenschr; 1994; 144(12-13):324-30. PubMed ID: 8650938 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility. Hegele RA; Breslow JL Genet Epidemiol; 1987; 4(3):163-84. PubMed ID: 2886398 [TBL] [Abstract][Full Text] [Related]
11. [Apolipoprotein(a)--a marker of the atherosclerotic process]. Titov VN Ter Arkh; 1993; 65(12):79-82. PubMed ID: 7511838 [No Abstract] [Full Text] [Related]
13. [A simple procedure for the simultaneous determination of apolipoproteins AI and B using rocket immunoelectrophoresis]. Oswald B; Winkler L; Schlag B; Dargel R Z Med Lab Diagn; 1984; 25(8):411-6. PubMed ID: 6441367 [No Abstract] [Full Text] [Related]
14. [The genetic bases of the lipid metabolic disorders in atherosclerosis]. TselÄko VI Tsitol Genet; 1996; 30(2):74-82. PubMed ID: 9281205 [TBL] [Abstract][Full Text] [Related]
15. [Determination of apolipoproteins AI and B: diagnostic significance and immunochemical methods]. Marcovina S Ric Clin Lab; 1984; 14 Suppl 2():75-94. PubMed ID: 6442453 [No Abstract] [Full Text] [Related]
16. [Pathogenetic bases of preventing atherosclerosis]. Chazov EI Ter Arkh; 1985; 57(11):29-33. PubMed ID: 4082018 [No Abstract] [Full Text] [Related]
17. Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism. Pati U; Pati N Mol Genet Metab; 2000; 71(1-2):87-92. PubMed ID: 11001801 [TBL] [Abstract][Full Text] [Related]
18. [Polymorphism of the DNA restriction fragment length flanking the insulin gene. A genetic marker for diabetic mellitus or atherosclerosis?]. Mandrup-Poulsen T; Owerbach D; Johansen K; Nerup J Ugeskr Laeger; 1985 Jun; 147(26):2065-71. PubMed ID: 2996193 [No Abstract] [Full Text] [Related]
19. [Lipoprotein(a). Its importance as an additional atherosclerosis marker]. Campos E Acta Med Port; 1997 Jan; 10(1):87-93. PubMed ID: 9245184 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein B gene polymorphisms in people in the east Mediterranean area of Turkey. Tamer L; Tanriverdi K; Ercan B; Unlu A; Sucu N; Pekdemir H; Atik U East Mediterr Health J; 2004; 10(1-2):125-30. PubMed ID: 16201717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]